Lu Chen

6PUBLICATIONS
34CO-AUTHORS
Liquid biopsiesMolecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 28, 2025
Low SVEP1 in intrahepatic cholangiocarcinoma mediates phenotype switching-driven metastasis by Jag2/Notch1/Hes5.

Lu Chen, Zhiqiang Han, Xiangdong Tian

|Jul 02, 2025
Inhibition of Wnt/β-catenin increases anti-tumor activity by synergizing with sorafenib in hepatocellular carcinoma.

Yuchao He, Dongming Liu, Aomei Ling

|Mar 04, 2025
CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance.

Meixi Wang, Fangdi Zou, Shengxin Wang

|Oct 03, 2024
Benefit of Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma: A Propensity Score-Matched Study.

Ruyu Han, Leijuan Gan, Liyu Sun

|Mar 12, 2024
Whole-Genome DNA Methylation Profiling of Intrahepatic Cholangiocarcinoma Reveals Prognostic Subtypes with Distinct Biological Drivers.

Haotian Liao, Xing Chen, Haichuan Wang

|Jan 03, 2022
Yap Expression Is Closely Related to Tumor Angiogenesis and Poor Prognosis in Hepatoblastoma.

Wenchen Gong, Zhiqiang Han, Feng Fang

Pageof 1

Frequent Collaborators

2 joint publications

Hua Guo

2 joint publications

Zhiqiang Han

2 joint publications

Tianqiang Song

1 joint publications

Haotian Liao